OmniAb saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of OmniAb’s patent filings and grants. Buy the databook here.
OmniAb has been focused on protecting inventions in Denmark(DK) with one publication in Q2 2024
The Denmark(DK) Patent Office dominates the patent filings with nearly 100% of filings. The Denmark(DK), and Finland(FI) patent Office are among the top ten patent offices where OmniAb is filings its patents. Among the top granted patent authorities, OmniAb has 100% of its grants in Finland(FI).
Regeneron Pharmaceuticals and Amgen could be the strongest competitors for OmniAb
For comprehensive analysis of OmniAb's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.